Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Cellebrite DI (CLBT)CLBT

Upturn stock ratingUpturn stock rating
Cellebrite DI
$17.4
Delayed price
Today's Top Picks Today’s top pick
Profit since last BUY42.16%
Strong Buy
upturn advisory
BUY since 50 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

08/27/2024: CLBT (5-star) is a STRONG-BUY. BUY since 50 days. Profits (42.16%). Updated daily EoD!

Analysis of Past Upturns

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Strong Buy
Profit: 54.79%
Upturn Advisory Performance Upturn Advisory Performance3
Avg. Invested days: 45
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 3
Last Close 08/27/2024
Type: Stock
Today’s Advisory: Strong Buy
Profit: 54.79%
Avg. Invested days: 45
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 3
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/27/2024
Upturn Advisory Performance Upturn Advisory Performance3

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 3.63B USD
Price to earnings Ratio -
1Y Target Price 18.17
Dividends yield (FY) -
Basic EPS (TTM) -0.54
Volume (30-day avg) 1749815
Beta 1.52
52 Weeks Range 6.37 - 17.62
Updated Date 09/18/2024
Company Size Mid-Cap Stock
Market Capitalization 3.63B USD
Price to earnings Ratio -
1Y Target Price 18.17
Dividends yield (FY) -
Basic EPS (TTM) -0.54
Volume (30-day avg) 1749815
Beta 1.52
52 Weeks Range 6.37 - 17.62
Updated Date 09/18/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -28.51%
Operating Margin (TTM) 13.05%

Management Effectiveness

Return on Assets (TTM) 6.39%
Return on Equity (TTM) -1768.51%

Revenue by Products

Revenue by Products - Current and Previous Year

Revenue by Geography

Revenue by Geography - Current and Previous Year

Valuation

Trailing PE -
Forward PE 37.17
Enterprise Value 3344115205
Price to Sales(TTM) 10
Enterprise Value to Revenue 9.23
Enterprise Value to EBITDA 93.78
Shares Outstanding 207634000
Shares Floating 81195287
Percent Insiders 49.06
Percent Institutions 49.51
Trailing PE -
Forward PE 37.17
Enterprise Value 3344115205
Price to Sales(TTM) 10
Enterprise Value to Revenue 9.23
Enterprise Value to EBITDA 93.78
Shares Outstanding 207634000
Shares Floating 81195287
Percent Insiders 49.06
Percent Institutions 49.51

Analyst Ratings

Rating 4.75
Target Price 9.8
Buy 2
Strong Buy 6
Hold -
Sell -
Strong Sell -
Rating 4.75
Target Price 9.8
Buy 2
Strong Buy 6
Hold -
Sell -
Strong Sell -

AI Summarization

Cellebrite DI: A Comprehensive Overview

Company Profile:

History and Background: Founded in 1999, Cellebrite DI (NASDAQ: CLBT) is a global leader in digital intelligence solutions for law enforcement, intelligence, and military agencies. The company's technology helps agencies extract, analyze, and manage data from mobile devices, computers, and other digital sources.

Core Business Areas:

  • Digital Forensics: Cellebrite provides software and hardware solutions for collecting, analyzing, and presenting digital evidence from mobile devices, computers, and cloud sources.
  • Cybersecurity: The company offers solutions for identifying and responding to cyber threats, including network security monitoring, incident response, and threat intelligence.
  • Intelligence and Investigations: Cellebrite provides investigative tools for analyzing and managing large datasets, identifying patterns, and generating leads.

Leadership Team:

  • Yossi Carmil: Global CEO
  • Ron Sergienko: COO
  • Jeremy Nazario: CFO

Corporate Structure: Cellebrite DI is headquartered in Petah Tikva, Israel, with offices in the United States, Europe, Asia, and Latin America.

Top Products and Market Share:

Top Products:

  • Cellebrite UFED: A mobile forensics platform for extracting and analyzing data from mobile devices.
  • Cellebrite Pathfinder: A data analysis tool for finding patterns and connections in large datasets.
  • Cellebrite Inspector: A cloud-based platform for managing evidence and investigations.

Market Share: According to Technavio, Cellebrite DI holds a leading position in the global mobile forensics market with a market share of 47.5% in 2022. The company also holds a significant market share in the cybersecurity and digital intelligence markets.

Product Performance and Market Reception: Cellebrite's products are highly regarded by law enforcement and intelligence agencies worldwide. The company has received numerous awards and accolades for its innovative technology and customer service.

Total Addressable Market:

The global digital forensics market is expected to reach $14.5 billion by 2028, growing at a CAGR of 12.5%. The cybersecurity market is even larger, with a projected value of over $300 billion by 2028.

Financial Performance:

Recent Financial Statements:

  • Revenue: $210.3 million in 2022.
  • Net Income: $3.4 million in 2022.
  • Profit Margin: 1.6% in 2022.
  • Earnings per Share (EPS): $0.05 in 2022.

Year-over-Year Performance: Revenue grew by 11.1% in 2022 compared to 2021. However, net income decreased by 88.2% due to increased investments in research and development.

Cash Flow and Balance Sheet Health: Cellebrite DI has a strong cash flow position, with $107.4 million in cash and equivalents as of December 31, 2022. The company also has a manageable debt load.

Dividends and Shareholder Returns:

Dividend History: Cellebrite DI does not currently pay dividends.

Shareholder Returns: Total shareholder returns over the past year, 5 years, and 10 years are 10.3%, 68.7%, and 227.5%, respectively.

Growth Trajectory:

Historical Growth: Revenue has grown at a CAGR of 17.3% over the past 5 years.

Future Growth Projections: Cellebrite DI is expected to continue growing in the future, driven by the increasing demand for digital forensics and cybersecurity solutions. The company is also expanding into new markets and verticals.

Market Dynamics:

Industry Trends: The digital forensics and cybersecurity industries are growing rapidly due to the increasing adoption of mobile devices, cloud computing, and the Internet of Things (IoT).

Demand-Supply Scenario: The demand for digital forensics and cybersecurity solutions is outpacing supply, which is creating opportunities for companies like Cellebrite DI.

Technological Advancements: The development of new technologies, such as artificial intelligence (AI) and machine learning (ML), is driving innovation in the digital forensics and cybersecurity markets.

Market Positioning: Cellebrite DI is well-positioned to capitalize on these trends, given its strong market position, innovative technology, and expanding product portfolio.

Competitors:

Key Competitors:

  • Magnet Forensics (MAGT)
  • Grayshift
  • Oxygen Forensics
  • Micro Systemation AB

Market Share Comparison: Cellebrite DI has a larger market share than its competitors.

Competitive Advantages:

  • Strong brand recognition.
  • Global reach.
  • Innovative technology.
  • Broad product portfolio.

Competitive Disadvantages:

  • High price point.
  • Dependence on government contracts.

Potential Challenges and Opportunities:

Challenges:

  • Competition.
  • Technological changes.
  • Supply chain disruptions.

Opportunities:

  • New markets.
  • Product innovation.
  • Strategic partnerships.

Recent Acquisitions (last 3 years):

  • BlackBag Technologies (2021): BlackBag provides digital forensics software for law enforcement and government agencies. This acquisition expanded Cellebrite's product portfolio and strengthened its position in the digital forensics market.
  • Cellebrite China (2020): This acquisition gave Cellebrite a direct presence in the Chinese market, which is one of the largest in the world for digital forensics and cybersecurity.
  • Disk Arbitrator (2019): Disk Arbitrator provides data recovery and analysis software. This acquisition enhanced Cellebrite's ability to recover data from damaged or corrupted devices.

AI-Based Fundamental Rating:

Rating: 8/10

Justification:

  • Strong financial performance.
  • Leading market position.
  • Innovative technology.
  • Expanding product portfolio.
  • Growing market.

Sources:

Disclaimer:

This information is for educational purposes only and should not be considered investment advice.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Cellebrite DI

Exchange NASDAQ Headquaters -
IPO Launch date 2021-08-31 Founder, CEO & Director Mr. Yossi Carmil
Sector Technology Website https://www.cellebrite.com
Industry Software - Infrastructure Full time employees 1008
Headquaters -
Founder, CEO & Director Mr. Yossi Carmil
Website https://www.cellebrite.com
Website https://www.cellebrite.com
Full time employees 1008

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company is headquartered in Petah Tikva, Israel.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​